Table 1

Background characteristics of the study groups at baseline

ERA (N=53)CRA (N=28)Controls (N=43)p Value
Women, N (%)45 (85)23 (82)38 (88)0.758
Age (years), mean±SD51±1552±1156±130.160
Number of teeth, median (IQR)27 (23–28)27 (22–28)27 (25–28)0.628
Rheumatoid factor present (%)42 (79.2)18 (69.2)3 (8.1)*<0.001
Disease duration (months), mean±SD10.4±17.1176±116.8<0.001
ESR (mm/hour), median (IQR)20 (11–34)20 (9–46)2 (2–10)*<0.001
CRP (mg/L), median (IQR)6 (3–14)18 (5–30)2 (2–3)*<0.001
DAS28, median (IQR)4.0 (3.2–4.8)4.1(3.0–4.9)0.974
Education, N (%)‡
 Lower20 (37.7)9 (36.0)16 (61)0.174
 Secondary27 (50.9)12 (48.0)6 (23.1)
 Higher6 (11.3)4 (16.0)4 (15.4)
Smoking, N (%)
 Never35 (66.0)23 (82.1)36 (83.7)
 Former7 (13.0)2 (7.0)1 (2.0)
Current11 (21.0)3 (11.0)6 (14.0)0.197
Alcohol use, N (%)
 Seldom/none28 (52.8)12 (42.9)13 (30.2)
 Monthly/weekly25 (47.2)16 (57.1)30 (69.8)0.084
  • *N=37, missing data from six control participants, no visit to laboratory.

  • †p value obtained by non-parametric Kruskal-Wallis test comparing patients with ERA and CRA.

  • ‡Missing data: 3 patients with CRA and 17 control participants for unknown reasons.

  • p Values by cross-tabulating with χ2 across the study groups.

  • CRA, chronic rheumatoid arthritis; CRP, serum C reactive protein level; DAS28, Disease Activity Score (28-joint count); ERA, early rheumatoid arthritis; ESR, erythrocyte sedimentation rate; N, number of patients.